HeartRhythm

JANUARY 26, 2024

Sympathetic nervous system hyperactivity plays a major role in the pathogenesis of ventricular arrhythmias following myocardial infarction (MI).1,2 3 Neuroinflammation has been implicated as a mechanism for sympathetic activation in cardiovascular disease.

Arrhythmia 80

Arrhythmia Sudden Cardiac Death Myocardial Infarction Tachycardia 80

Frontiers in Cardiovascular Medicine

MARCH 27, 2024

We reported the case of a 51-year-old woman who experienced multiple types of arrhythmias over three decades and was diagnosed with Danon disease late by genetic testing. She denied any family history of cardiovascular disease or sudden death. 696T>A; p.Cys232Ter), which confirmed the diagnosis of Danon disease.

Arrhythmia 59

Arrhythmia Atrial Flutter Tachycardia Atrial Fibrillation 59

DAIC

MAY 10, 2024

milla1cf Fri, 05/10/2024 - 08:17 May 10, 2024 — With cardiovascular disease being a leading cause of mortality worldwide, Vivalink , a leading provider of digital healthcare solutions, announces the launch of its comprehensive technology solution designed for Mobile Cardiac Telemetry (MCT) and Holter monitoring.

Technology 105

Technology Arrhythmia Heart Rhythm Cardiovascular Disease 105

HeartRhythm

APRIL 30, 2024

The association between exercise and cardiac arrhythmias is less certain.

Arrhythmia 40

Arrhythmia Cardiovascular Disease Exercise 40

DAIC

FEBRUARY 2, 2024

milla1cf Fri, 02/02/2024 - 17:18 February 2, 2024 — GE HealthCare (Nasdaq: GEHC) announces the latest innovation in electrophysiology (EP), the Prucka 3 with CardioLab EP Recording system, to help clinicians in the diagnosis and treatment of cardiac arrhythmias. million people died from cardiovascular diseases in 2019.

Electrophysiology 101

Electrophysiology Innovation AFIB Atrial Fibrillation 101

DAIC

JUNE 18, 2024

A projected rise in heart disease and stroke – along with several key risk factors, including high blood pressure and obesity – is likely to triple related costs to $1.8 population could be affected by cardiovascular disease within the next 30 years, according to two new science reports. to 61% of the U.S. population.

Heart Disease 105

Heart Disease Blood Pressure Cardiovascular Disease Strokes 105

Frontiers in Cardiovascular Medicine

JUNE 6, 2024

IntroductionArrhythmia is an important indication of underlying cardiovascular diseases (CVD) and is prevalent worldwide. Accurate diagnosis of arrhythmia is crucial for timely and effective treatment. Electrocardiogram (ECG) plays a key role in the diagnosis of arrhythmia.

Arrhythmia 45

Arrhythmia Electrocardiogram Cardiovascular Disease 45

Journal of the American Heart Association

MARCH 4, 2025

In the setting of arrhythmias, specific SDoHs can increase the incidence of atrial fibrillation and adversely affect major outcomes in these patients. In congenital heart diseases, SDoHs can affect major outcomes, as well.

Cardiovascular Disease 40

Cardiovascular Disease Peripheral Arterial Disease Congenital Heart Disease Coronary Artery Disease 40

DAIC

FEBRUARY 14, 2025

The TAILORED-AF trial, highlights AIs ability to help physicians treat cardiovascular disease and improve patient outcomes. These patients represent a more advanced AF disease progression. In fact, this is the first large-scale international RCT in interventional cardiology demonstrating superior efficacy through the use of AI.

Atrial Fibrillation 52

Atrial Fibrillation Ablation Technology Pulmonary 52

HeartRhythm

APRIL 30, 2024

Environmental noise has been implicated in the pathogenesis of cardiovascular disease and ventricular arrhythmias, with evidence indicating a correlation between ANS upregulation and noise-induced arrhythmias.

Arrhythmia 40

Arrhythmia Cardiovascular Disease 40

HeartRhythm

OCTOBER 24, 2024

Patients with nonalcoholic fatty liver disease (NAFLD) are at risk for cardiovascular diseases. Less is known about the relationship between NAFLD, ventricular arrhythmias (VAs), and cardiovascular events.

Arrhythmia 40

Arrhythmia Defibrillator Cardiovascular Disease 40

MIBHS

JANUARY 15, 2025

Smoking is a well-known health hazard, contributing to a wide array of diseases and conditions. Its effects on the heart are particularly alarming, as smoking significantly increases the risk of cardiovascular diseases (CVDs) and complicates medical procedures such as minimally invasive or bloodless heart surgeries.

Coronary Artery Bypass Graft 52

Coronary Artery Bypass Graft Blood Clot Blood Pressure Plaque 52

HeartRhythm

FEBRUARY 6, 2024

Emerging evidence has linked daytime napping with the risk of cardiovascular events. Cardiac arrhythmias are considered as early-stage clinical stage for cardiovascular diseases. However, whether napping frequency is associated with incident arrhythmias remains unknown.

Arrhythmia 40

Arrhythmia Cardiovascular Disease 40

HeartRhythm

APRIL 30, 2024

It is strongly associated with faster progression of cardiovascular diseases and an increased risk of mortality. The relationship between sarcopenia and ventricular arrhythmia (VA) is unknown. Sarcopenia is a geriatric syndrome featuring muscle mass, strength, and function loss.

Sudden Cardiac Death 40

Sudden Cardiac Death Arrhythmia Cardiovascular Disease 40

DAIC

JANUARY 3, 2024

The Zio monitor ECG System secured its CE mark based on compliance to EU MDR standards of performance, quality, safety, and efficacy, along with the body of clinical evidence supporting Zio in detecting potential cardiac arrhythmias. Diagnostic Utility of a Novel Leadless Arrhythmia Monitoring Device, American Journal of Cardiology , 2013.

Technology 98

Technology Certification Arrhythmia Electrocardiogram 98

HeartRhythm

JUNE 4, 2024

Diabetes mellitus (DM) confers an increased risk of sudden cardiac death (SCD) independent of its associated cardiovascular comorbidities. Diabetes mellitus induces adverse structural, electrophysiological, and autonomic cardiac remodeling which can increase one’s risk of ventricular arrhythmias and SCD.

Sudden Cardiac Death 40

Sudden Cardiac Death Arrhythmia Diabetes Electrophysiology 40

Frontiers in Cardiovascular Medicine

JULY 2, 2024

Cardiovascular diseases account for a significant portion of the worldwide mortality rate. This aroused interest among the specialised scientific community, seeking for solutions based on non-clinical and clinical investigations, to shed light onto the physio-pathology of cardiovascular impairment.

Atherosclerosis 52

Atherosclerosis Cardiovascular Disease Physiology Biomarkers 52

Frontiers in Cardiovascular Medicine

APRIL 4, 2024

The experimental results show that the proposed technique is superior to the existing wavelet based approach and NLM filtering, with the higher SNR and structure similarity index measure (SSIM), the lower root mean squared error (RMSE) and percent root mean square difference (PRD).ConclusionsThe

Electrocardiogram 52

Electrocardiogram Cardiovascular Disease Arrhythmia 52

Heart BMJ

JUNE 17, 2024

Learning objectives To review the potential arrhythmia complications during pregnancy and puerperium in women with and without known cardiovascular disease. To recognise arrhythmia conditions associated with a high risk of pregnancy-related cardiac complications for which intervention before considering pregnancy is appropriate.

Arrhythmia 45

Arrhythmia Bradycardia Document Tachycardia 45

Cardiomatics

NOVEMBER 12, 2024

Cardiovascular diseases, including arrhythmias, are a growing health concern in sub-Saharan Africa. The research team, including experts from UCSF, Weill Cornell Medicine, and Cardiomatics, examined arrhythmia prevalence and ways to build research capacity in the region.

Electrophysiology 52

Electrophysiology Arrhythmia Research Cardiovascular Disease 52

HeartRhythm

APRIL 30, 2024

Electrocardiogram (ECG) is a simple, noninvasive screening method for cardiovascular disease and arrhythmia. The impact of ECG abnormality on mortality is not certain in low-risk populations.

Electrocardiogram 40

Electrocardiogram Cardiovascular Disease Arrhythmia 40

DAIC

APRIL 30, 2024

However, the risk of arrhythmias following this procedure is reportedly high. Cardiovascular diseases are still among the top causes of death worldwide, and especially prevalent in developed countries. The highly positive outcomes observed in primate models highlight the potential of this strategy.

Transplant 105

Transplant Heart Transplant Myocardial Infarction Heart Attack 105

DAIC

FEBRUARY 27, 2024

a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTechi , announced the commencement of patient cases with the investigational Laminar Left Atrial Appendage Elimination (LAAX) System as part of its pivotal investigational device exemption (IDE) study.

Atrial Fibrillation 105

Atrial Fibrillation Innovation AFIB Pharmacology 105

Cardiology Update

JANUARY 12, 2025

Hashtag: #ACC25 European Heart Rhythm Association (EHRA) Congress 2025 Date: 30 March to 1 April 2025 Location: Vienna and online Overview: The yearly gathering of the European Heart Rhythm Association (EHRA) unites scientists, healthcare professionals, and other stakeholders engaged in the global management of arrhythmias.

Heart Failure 52

Heart Failure Atherosclerosis Heart Rhythm Nursing 52

HeartRhythm

APRIL 15, 2024

Leukocyte immunoglobulin-like receptor B4a (Lilrb4a) is an immunosuppressive regulatory receptor and plays a vital role in cardiovascular disease. However, the effect of Lilrb4a on ventricular arrhythmias from ISO-induced mice model remains unclear.

Heart Failure 40

Heart Failure Cardiovascular Disease Arrhythmia 40

Frontiers in Cardiovascular Medicine

MARCH 6, 2024

Cardiomyopathy, a heterogeneous pathological condition characterized by changes in cardiac structure or function, represents a significant risk factor for the prevalence and mortality of cardiovascular disease (CVD). Research conducted over the years has led to the modification of definition and classification of cardiomyopathy.

Cardiomyopathy 59

Cardiomyopathy Diabetes Article Obesity 59

BoardVitals - Cardiovascular

JUNE 14, 2017

Preparing for the ABIM Cardiovascular Disease Board Exam is no easy feat. Have a go at 6 cardiology board exam sample questions that will definitely test your knowledge and see if you’re as prepared as you think you are for the cardiology boards. We hope you performed well.

Congenital Heart Disease 52

Congenital Heart Disease Coronary Angiogram Coronary Artery Disease Cardiovascular Disease 52

AMS Cardiology

OCTOBER 11, 2023

and discuss the critical role of genetics in heart disease prevention. Is Heart Disease Genetic ? Cardiovascular disease is a leading cause of death worldwide. It encompasses a range of conditions, including coronary artery disease, heart failure and arrhythmias.

Heart Disease 52

Heart Disease Genetic predisposition Diet Genetic Markers 52

Cardiometabolic Health Congress

SEPTEMBER 13, 2024

The European Society of Cardiology (ESC) Congress 2024 (August 30 – September 2, 2024) has wrapped up, delivering groundbreaking insights into cardiovascular diseases and related conditions. ILRs detected various arrhythmias, with ventricular arrhythmias linked to spontaneous type 1 ECGs and fever.

Hypertension 59

Hypertension Cardiovascular Disease Bicuspid/Mitral Arrhythmia 59

DAIC

JANUARY 19, 2024

Chugh’s leadership in arrhythmia research and care is extraordinary,” said Eduardo Marbán, MD, PhD , executive director of the Smidt Heart Institute. The award recognizes major contributions to the advancement of scientific knowledge in the field of cardiovascular disease.

Cardiac Arrest 105

Cardiac Arrest Heart Rhythm Electrophysiology Sudden Cardiac Death 105

Frontiers in Cardiovascular Medicine

OCTOBER 10, 2024

Despite significant advances in diagnosis and treatment over recent decades, cardiovascular disease (CVD) remains one of the leading causes of morbidity and mortality in Western countries.

Atherosclerosis 52

Atherosclerosis Heart Failure Cardiomyopathy Cardiovascular Disease 52

Frontiers in Cardiovascular Medicine

JANUARY 23, 2024

Introduction Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in kidney transplant recipient (KTR). There is a dearth of standardized guidelines on optimal cardiovascular evaluation of transplant candidates.

Transplant 64

Transplant Coronary Artery Disease Myocardial Infarction Cardiovascular Disease 64

Frontiers in Cardiovascular Medicine

JUNE 6, 2024

Cardio-oncology is a new field of interest in cardiology focusing on the detection and treatment of cardiovascular diseases, such as arrhythmias, myocarditis, and heart failure, as side-effects of chemotherapy and radiotherapy. The association between chemotherapeutic agents and arrhythmias has previously been established.

Tachycardia 40

Tachycardia Cancer Cardio Oncology Arrhythmia 40

Circulation

MARCH 11, 2024

Hematopoietic stem cell transplantation can cure various disorders but poses cardiovascular risks, especially for elderly patients and those with cardiovascular diseases. Cardiovascular evaluations are crucial in pretransplantation assessments, but guidelines are lacking. Circulation, Ahead of Print.

Transplant 45

Transplant Cardiovascular Disease Atrial Fibrillation Pediatrics 45

HeartRhythm

OCTOBER 19, 2023

Hypertrophic cardiomyopathy (HCM)-related sudden cardiac death (SCD) rates with contemporary management are low; however, high-intensity exercise can induce fatal arrhythmias in HCM patients. Thus, current guidelines recommend avoiding high-intensity exercise in HCM patients at high risk for SCD1,2.

Exercise 40

Exercise Cardiomyopathy Sudden Cardiac Death Cardiovascular Disease 40

HeartRhythm

NOVEMBER 5, 2024

Atrial fibrillation (AF) is the most common arrhythmia in the U.S., Black Americans are less prone to develop AF than White Americans, but they display a higher burden of modifiable risk factors for cardiovascular disease and higher rates of ischemic stroke.

Atrial Fibrillation 40

Atrial Fibrillation Risk Factors Genetic predisposition Cardiovascular Disease 40

DAIC

JULY 15, 2024

Health systems leveraging Guidehealth can seamlessly integrate Story Health’s program to support at-risk patients with heart conditions like heart failure, hypertension, and arrhythmia, providing better care while also reducing the total cost of care, according to a written statement detailing the deal.

Technology 105

Technology Innovation Nursing Heart Failure 105